Published date: 24 March 2023
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
WA7 2ES
Value of contract
£264,003,000
Procurement reference
CF-1377900D0O000000rwimUAA
Published date
24 March 2023
Closing date
28 November 2022
Closing time
1pm
Contract start date
1 April 2023
Contract end date
28 February 2026
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023
Offer reference number: CM/PHR/22/5660
CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
More information
Attachments
-
- 5660_02 Transparency Award Schedule.pdf
- 5660_02 Transparency Award Schedule
-
- 5660_03 Transparency Award Schedule.pdf
- 5660_03 Transparency Award Schedule
-
- 5660_04 Transparency Award Schedule.pdf
- 5660_04 Transparency Award Schedule
-
- 030223-2022 FTS Opportunity National Framework Agreement for Adalimumab Injection 1 April 2023.pdf
- 030223-2022 FTS Opportunity National Framework Agreement for Adalimumab Injection 1 April 2023
-
- 5660_01 Transparency Award Schedule.pdf
- 5660_01 Transparency Award Schedule
-
- Parties Appointed to the framework CM-PHR-22-5660.xlsx
- Parties Appointed to the framework CM-PHR-22-5660
-
- 03 Framework Agreement and Terms and Conditions - CM_PHR_22_5660 - National Framework Agreement for Adalimumab Injection April 2023.docx
- 03 Framework Agreement and Terms and Conditions - CM_PHR_22_5660 - National Framework Agreement for Adalimumab Injection April 2023
Award information
Awarded date
3 March 2023
Contract start date
1 April 2023
Contract end date
28 February 2026
Total value of contract
£264,003,228
This contract was awarded to 6 suppliers.
Amgen Ltd
Address
216 Science Park Milton Road, Cambridge, CB4 0WA
Reference
None
Supplier is SME?
No
Sandoz Ltd
Address
Park View, Riverside Way, Watchmoor Park,, Camberley, Surrey., GU15 3YL
Reference
None
Supplier is SME?
Yes
Biogen
Address
Innovation House 70 Norden Road, Maidenhead Berkshire, SL6 4AY
Reference
None
Supplier is SME?
No
Abbvie Ltd
Address
Abbvie House, Vanwall Business Park, Vanwall Road,, Maidenhead, Berks., SL6 4UB
Reference
None
Supplier is SME?
No
Fresenius Kabi Limited
Address
Cestrian Court, Eastgate Way, Manor Park,, Runcorn, Cheshire,, WA7 1NT
Reference
None
Supplier is SME?
No
Celltrion Healthcare United Kingdom Limited
Address
The Switch ,1-7 The Grove,, Slough, SL1 1QP
Reference
None
Supplier is SME?
No
About the buyer
Contact name
Katie Noonan
Address
2nd Floor Rutland House
Runcorn
WA7 2ES
GB
Share this notice
Closing: 28 November 2022, 1pm